Xue Li
Xue Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chen-Zhong Li
Department of Biomedical Engineering, School of Medicine, The Chinese University of Hong Kong (Shenzhen)
2 shared publications - Shan Liu
Sichuan Provincial Key Laboratory for Human Disease Gene Study, Department of Medical Genetics, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China
2 shared publications - Chang Su
Department of Gastrointestinal Surgery, Minhang Hospital Affiliated to Fudan University, Shanghai, China
1 shared publication - Cheng Yin
Department of Neurosurgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication - Hong Tan
Department of General Surgery, Chengdu Integrated TCM&Western Medicine Hospital (Chengdu First People's Hospital) 8 , Chengdu 610041, China
1 shared publication - Hongzhi Luo
West China Hospital Sichuan University Jintang Hospital, Jintang First People’s Hospital, Chengdu 610400, China
1 shared publication
Latest Publications
- Open Access
- 24 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8, 0564
Fluorescent Particles Based on Aggregation-Induced Emission for Optical Diagnostics of the Central Nervous System
In 2001, Tang’s team discovered a unique type of luminogens with substantial enhanced fluorescence upon aggregation and introduced the concept of “aggregation-induced emission (AIE)”. Unlike conventional fluorescent materials, AIE luminogens (AIEgens) emit weak or no fluorescence in solution but become highly fluorescent in aggregated or solid states, due to a mechanism known as restriction of intramolecular motions (RIM). Initially considered a purely inorganic chemical phenomenon, AIE was later applied in biomedicine to improve the sensitivity of immunoassays. Subsequently, AIE has been extensively explored in various biomedical applications, especially in cell imaging. Early studies achieved nonspecific cell imaging using nontargeted AIEgens, and later, specific cellular imaging was realized through the design of targeted AIEgens. These advancements have enabled the visualization of various biomacromolecules and intracellular organelles, providing valuable insights into cellular microenvironments and statuses. Neurological disorders affect over 3 billion people worldwide, highlighting the urgent need for advanced diagnostic and therapeutic tools. AIEgens offer promising opportunities for imaging the central nervous system (CNS), including nerve cells, neural tissues, and blood vessels. This review focuses on the application of AIEgens in CNS imaging, exploring their roles in the diagnosis of various neurological diseases. We will discuss the evolution and conclude with an outlook on the future challenges and opportunities for AIEgens in clinical diagnostics and therapeutics of CNS disorders.
- 24 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8, 0564
Open AccessFluorescent Particles Based on Aggregation-Induced Emission for Optical Diagnostics of the Central Nervous System
In 2001, Tang’s team discovered a unique type of luminogens with substantial enhanced fluorescence upon aggregation and introduced the concept of “aggregation-induced emission (AIE)”. Unlike conventional fluorescent materials, AIE luminogens (AIEgens) emit weak or no fluorescence in solution but become highly fluorescent in aggregated or solid states, due to a mechanism known as restriction of intramolecular motions (RIM). Initially considered a purely inorganic chemical phenomenon, AIE was later applied in biomedicine to improve the sensitivity of immunoassays. Subsequently, AIE has been extensively explored in various biomedical applications, especially in cell imaging. Early studies achieved nonspecific cell imaging using nontargeted AIEgens, and later, specific cellular imaging was realized through the design of targeted AIEgens. These advancements have enabled the visualization of various biomacromolecules and intracellular organelles, providing valuable insights into cellular microenvironments and statuses. Neurological disorders affect over 3 billion people worldwide, highlighting the urgent need for advanced diagnostic and therapeutic tools. AIEgens offer promising opportunities for imaging the central nervous system (CNS), including nerve cells, neural tissues, and blood vessels. This review focuses on the application of AIEgens in CNS imaging, exploring their roles in the diagnosis of various neurological diseases. We will discuss the evolution and conclude with an outlook on the future challenges and opportunities for AIEgens in clinical diagnostics and therapeutics of CNS disorders.
- 19 July 2024
- Published by AIP Publishing in Applied Physics Reviews
- Vol. 11 (3)
Carbon-based implantable bioelectronics
Real-time health monitoring and precision treatment are important in the biomedical field. Researchers have focused on unique gadgets with peculiar functions, which have emerged from the merging of electronic components with biological systems. Because implantable bioelectronics can sense bodily information or elicit bodily reactions in living creatures from sites outside the body, they are becoming helpful and promising remedies for a variety of ailments. Carbon materials are more suitable than other materials for the manufacture of implantable medical electronics due to their excellent biocompatibility, fatigue resistance, and low specific gravity. Therefore, carbon materials can apply to a wide range of implantable drug delivery devices, biosensors, therapeutic stimulators, and energy storage and play irreplaceable roles in neurological, cardiovascular, gastrointestinal, and locomotor systems, among others. This review aims to offer researchers insight into carbon-based implantable bioelectronics in the biomedical field. Initially, various types of carbon materials were introduced. Subsequently, it delves into carbon-based implantable bioelectronics from four perspectives: implantable actuators, biosensors, drug delivery systems, and power supplies. Furthermore, we anticipate the future direction and potential applications of carbon-based implantable bioelectronics. Given the evolving field of nanotechnology and bioelectronics, we are optimistic that these devices will foster significant breakthroughs and innovations in the biomedical sector. Ultimately, this review aims to assist researchers in navigating the choices and directions of carbon-based implantable bioelectronics, thereby promoting the advancement of the biomedical field and contributing positively to the health and welfare of humankind.
- 19 July 2024
- Published by AIP Publishing in Applied Physics Reviews
- Vol. 11 (3)
Carbon-based implantable bioelectronics
Real-time health monitoring and precision treatment are important in the biomedical field. Researchers have focused on unique gadgets with peculiar functions, which have emerged from the merging of electronic components with biological systems. Because implantable bioelectronics can sense bodily information or elicit bodily reactions in living creatures from sites outside the body, they are becoming helpful and promising remedies for a variety of ailments. Carbon materials are more suitable than other materials for the manufacture of implantable medical electronics due to their excellent biocompatibility, fatigue resistance, and low specific gravity. Therefore, carbon materials can apply to a wide range of implantable drug delivery devices, biosensors, therapeutic stimulators, and energy storage and play irreplaceable roles in neurological, cardiovascular, gastrointestinal, and locomotor systems, among others. This review aims to offer researchers insight into carbon-based implantable bioelectronics in the biomedical field. Initially, various types of carbon materials were introduced. Subsequently, it delves into carbon-based implantable bioelectronics from four perspectives: implantable actuators, biosensors, drug delivery systems, and power supplies. Furthermore, we anticipate the future direction and potential applications of carbon-based implantable bioelectronics. Given the evolving field of nanotechnology and bioelectronics, we are optimistic that these devices will foster significant breakthroughs and innovations in the biomedical sector. Ultimately, this review aims to assist researchers in navigating the choices and directions of carbon-based implantable bioelectronics, thereby promoting the advancement of the biomedical field and contributing positively to the health and welfare of humankind.
- Open Access
- 16 June 2023
- Published by KEAI Publishing in Virtual Reality & Intelligent Hardware
- Vol. 5 (3) , 266-278
Data-based real-time petrochemical gas diffusion simulation approach on virtual reality
- 16 June 2023
- Published by KEAI Publishing in Virtual Reality & Intelligent Hardware
- Vol. 5 (3) , 266-278
Open AccessData-based real-time petrochemical gas diffusion simulation approach on virtual reality